The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 20, 2018

Filed:

Apr. 08, 2015
Applicants:

Pablo E. Vivas-mejia, San Juan, PR (US);

Jeyshka M. Reyes Gonzalez, San Juan, PR (US);

Anil K. Sood, Houston, TX (US);

Inventors:

Pablo E. Vivas-Mejia, San Juan, PR (US);

Jeyshka M. Reyes Gonzalez, San Juan, PR (US);

Anil K. Sood, Houston, TX (US);

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); A61K 9/127 (2006.01); A61K 31/7088 (2006.01); A61K 33/24 (2006.01); A61K 45/06 (2006.01); A61K 31/713 (2006.01); C12N 15/11 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1272 (2013.01); A61K 9/0019 (2013.01); A61K 9/1271 (2013.01); A61K 31/7088 (2013.01); A61K 31/713 (2013.01); A61K 33/24 (2013.01); A61K 45/06 (2013.01); C12N 15/11 (2013.01); C12N 2320/31 (2013.01); C12N 2320/32 (2013.01);
Abstract

The present invention discloses c-MYC-siRNA formulation as a potential therapeutic target for cisplatin-resistant ovarian cancer. It is disclosed targeting c-MYC with small interfering RNA (siRNA) in the cisplatin-resistant ovarian cancer cell line inducing a significant cell growth arrest and inhibition of cell proliferation. Apoptosis and arrest of cell cycle progression were also observed after c-MYC-siRNA-based silencing of c-MYC. Furthermore, delivering nanoliposomal c-MYC-siRNA, decreased tumor weight and number of tumor nodules compared with a liposomal-negative control siRNA.


Find Patent Forward Citations

Loading…